Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Osteosarcoma 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Filgrastim 4Proton Therapy 3Docetaxel 3regorafenib 2Sunitinib 2Ifosfamide 2Gemcitabine 2Carboplatin 2temsirolimus 1pegfilgrastim 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1ivosidenib 1itacitinib 1etoposide phosphate 1capivasertib 1baricitinib 1apatinib 1angiotensin I (1-7) 1abemaciclib 1Zoledronic Acid 1Weight-Bearing 1Trabectedin 1Topotecan 1Thiotepa 1Thalidomide 1Taxes 1TQ-B3525 1Surveys and Questionnaires 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chondrosarcoma × angiotensin I (1-7) × Clear all
NCT01553539 2018-07-05

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Wake Forest University Health Sciences

Phase 2 Completed
20 enrolled 10 charts
Sarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡